World's Best Scientists 2026 revealed!
Egbert F. Smit

Egbert F. Smit

Last Updated:

D-Index & Metrics

?
Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 115 4481 4204 168 164 782 58941

Egbert F. Smit publications per year

The chart shows the history of publications by Egbert F. Smit between 1989 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Egbert F. Smit published across 37 years, from 1989 to 2025, averaging 28.3 papers a year. Output peaked at 157 publications in 2023. 127 of the 1,048 publications appeared in the last two years.

No. of publications
50 100 150
Bar chart. Horizontal axis: year, 1989 to 2025. Vertical axis: number of publications, 0 to 157. Peak 157 publications in 2023. 1989: 4 publications 1990: 2 publications 1991: 2 publications 1992: 3 publications 1993: 3 publications 1994: 2 publications 1995: 3 publications 1996: 0 publications 1997: 2 publications 1998: 2 publications 1999: 11 publications 2000: 15 publications 2001: 14 publications 2002: 11 publications 2003: 14 publications 2004: 9 publications 2005: 18 publications 2006: 12 publications 2007: 26 publications 2008: 21 publications 2009: 27 publications 2010: 35 publications 2011: 39 publications 2012: 51 publications 2013: 43 publications 2014: 58 publications 2015: 50 publications 2016: 42 publications 2017: 54 publications 2018: 31 publications 2019: 44 publications 2020: 30 publications 2021: 53 publications 2022: 33 publications 2023: 157 publications 2024: 94 publications 2025: 33 publications
1989 2025

1,048 publications in total across all disciplines

View publications per year as a table
Egbert F. Smit: publications per year, 1989 to 2025
Year Publications
1989 4
1990 2
1991 2
1992 3
1993 3
1994 2
1995 3
1996 0
1997 2
1998 2
1999 11
2000 15
2001 14
2002 11
2003 14
2004 9
2005 18
2006 12
2007 26
2008 21
2009 27
2010 35
2011 39
2012 51
2013 43
2014 58
2015 50
2016 42
2017 54
2018 31
2019 44
2020 30
2021 53
2022 33
2023 157
2024 94
2025 33
Total 1,048
Download as CSV

Egbert F. Smit publications per year - data summary

  • Egbert F. Smit, a Medicine scholar from VU University Medical Center, has 1,048 publications recorded across 37 years, from 1989 to 2025.
  • The oldest publication on record dates to 1989 and the most recent to 2025.
  • The most productive year is 2023, with 157 publications.
  • The least productive years with any output are 1990, 1991, 1994, 1997 and others, with 2 publications each.
  • 1 of the 37 years in the span carries no publications at all (1996).
  • The rate of publication averages 28.3 papers per year over the whole span, or 29.1 per year counting only the 36 years with at least one publication.
  • The last 5 years on the chart (2021-2025) hold 370 publications, 35% of the career total.
  • Split into equal eras - 1989-2001: 63 publications (4.8 per year); 2002-2014: 364 publications (28.0 per year); 2015-2025: 621 publications (56.5 per year).
  • Comparing the opening and closing eras, the overall trend of publication is rising.

Egbert F. Smit publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Egbert F. Smit sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 781–800 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 782 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217 782
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Egbert F. Smit publication distribution in Medicine in 2026 - data summary

  • The chart plots the publication count of all 20,134 Medicine scientists ranked by Research.com in 2026, grouped into 86 ranges running from 101–120 to 1,796+ publications.
  • Egbert F. Smit, a Medicine scholar from VU University Medical Center, records 782 publications - the 86th percentile of the discipline.
  • 86% of ranked Medicine scientists score the same or lower than Egbert F. Smit, and about 14% score higher.
  • The median of the discipline falls in the 441–460 publications range, and Egbert F. Smit ranks above the median.
  • The most crowded range is 341–360 publications, holding 922 scientists (5% of the field).
  • 64% of the field sits in the lowest quarter of the value range (up to 521–540 publications), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 1,796 publications or more, 100 scientists in all (<1% of the field).

Egbert F. Smit D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Egbert F. Smit sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 114–115 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393 115
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Egbert F. Smit D-index placement in Medicine in 2026 - data summary

  • The chart plots the discipline H-index (D-index) of all 20,134 Medicine scientists ranked by Research.com in 2026, grouped into 75 ranges running from 70–71 to 217+ D-Index.
  • Egbert F. Smit, a Medicine scholar from VU University Medical Center, records 115 D-Index - the 78th percentile of the discipline.
  • 78% of ranked Medicine scientists score the same or lower than Egbert F. Smit, and about 22% score higher.
  • The median of the discipline falls in the 94–95 D-Index range, and Egbert F. Smit ranks above the median.
  • The most crowded range is 82–83 D-Index, holding 1,027 scientists (5% of the field).
  • 70% of the field sits in the lowest quarter of the value range (up to 106–107 D-Index), so the distribution is heavily right-skewed and high scores are rare.
  • The final bar has no upper bound: it groups every scientist with 217 D-Index or more, 98 scientists in all (<1% of the field).

Overview

Egbert F. Smit is affiliated with VU University Medical Center in the Netherlands and has a research focus primarily within the field of Medicine, with notable expertise in pulmonary and respiratory medicine, oncology, and cancer research.

Their work covers key areas such as lung cancer treatments and mutations, lung cancer diagnosis and treatment, colorectal cancer studies, cancer immunotherapy and biomarkers, as well as molecular biology and cancer genomics.

Frequent publication venues for Smit include the following:

  • Annals of Oncology
  • Journal of Clinical Oncology
  • Journal of Thoracic Oncology
  • Lung Cancer
  • Cancer Research

Collaborations are an important aspect of their research, with frequent coauthors being:

  • Enriqueta Felip
  • Anne-Marie C. Dingemans
  • Kim Monkhorst
  • Adrianus J. de Langen
  • Vincent van der Noort

Recent publications illustrate a focus on oncogene-addicted and non-oncogene-addicted metastatic non-small-cell lung cancer, as well as targeted treatments and mutations. Notable papers include:

  • "Capmatinib in MET Exon 14-Mutated or MET -Amplified Non-Small-Cell Lung Cancer," 2020, New England Journal of Medicine
  • "Trastuzumab Deruxtecan in HER2 -Mutant Non-Small-Cell Lung Cancer," 2021, New England Journal of Medicine
  • "Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations," 2020, New England Journal of Medicine
  • "Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up," 2023, Annals of Oncology
  • "Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up," 2023, Annals of Oncology

Their publications have garnered significant citations, with some papers cited over 900 times, reflecting the relevance of their research within the field.

Best Publications

  • Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

    Masahiro Fukuoka;Seiji Yano;Giuseppe Giaccone;Tomohide Tamura

  • Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

    Luis Paz-Ares;Mikhail Dvorkin;Yuanbin Chen;Niels Reinmuth

  • Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    Martin Peifer;Lynnette Fernández-Cuesta;Martin L. Sos;Julie George

  • Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

    Joe Y Chang;Suresh Senan;Marinus A. Paul;Reza John Mehran

  • Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial

    David Planchard;Egbert F Smit;Harry J M Groen;Julien Mazieres

  • Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

    Harm Van Tinteren;Otto S. Hoekstra;Egbert F. Smit;Jan H.A.M. Van Den Bergh

  • Long-term expanding human airway organoids for disease modeling

    Norman Sachs;Angelos Papaspyropoulos;Domenique D. Zomer-van Ommen;Inha Heo

  • Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer

    Jonathan Weiss;Martin L. Sos;Danila Seidel;Martin Peifer

  • Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids

    Krijn K Dijkstra;Chiara M Cattaneo;Fleur Weeber;Myriam Chalabi

  • Pan-cancer whole-genome analyses of metastatic solid tumours

    Peter Priestley;Jonathan Baber;Martijn P. Lolkema;Neeltje Steeghs

  • RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics

    Myron G. Best;Nik Sol;Irsan Kooi;Jihane Tannous

  • Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer

    Jan P. van Meerbeeck;Gijs W. P. M. Kramer;Paul E. Y. Van Schil;Catherine Legrand

  • A genomics-based classification of human lung tumors

    Danila Seidel;Thomas Zander;Lukas C. Heukamp;Martin Peifer

  • Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations

    Paul K. Paik;Enriqueta Felip;Remi Veillon;Hiroshi Sakai

  • Trastuzumab Deruxtecan in HER2-Mutant Non-Small-Cell Lung Cancer.

    Bob T Li;Egbert F Smit;Yasushi Goto;Kazuhiko Nakagawa

  • Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non-Small-Cell Lung Cancer

    Frank J. Lagerwaard;Cornelis J.A. Haasbeek;Egbert F. Smit;Ben J. Slotman

  • Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial

    Dong-Wan Kim;Dong-Wan Kim;Marcello Tiseo;Myung-Ju Ahn;Karen L Reckamp

  • 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

    J. Vansteenkiste;L. Crinò;C. Dooms;J. Y. Douillard

  • Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.

    Jonathan W Goldman;Mikhail Dvorkin;Yuanbin Chen;Niels Reinmuth

  • Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel Plus Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group—EORTC 08975

    Egbert F. Smit;Jan P.A.M. van Meerbeeck;Pilar Lianes;Channa Debruyne

Frequent Co-Authors

Pieter E. Postmus
Pieter E. Postmus Leiden University Medical Center
Harry J.M. Groen
Harry J.M. Groen University Medical Center Groningen
Suresh Senan
Suresh Senan University of Amsterdam
Otto S. Hoekstra
Otto S. Hoekstra Amsterdam UMC
Anne-Marie C. Dingemans
Anne-Marie C. Dingemans Erasmus University Rotterdam
Ronald Boellaard
Ronald Boellaard Amsterdam UMC
Adriaan A. Lammertsma
Adriaan A. Lammertsma VU University Medical Center
Peter J.F. Snijders
Peter J.F. Snijders Vrije Universiteit Amsterdam
Giuseppe Giaccone
Giuseppe Giaccone Cornell University
Luis Paz-Ares
Luis Paz-Ares Complutense University of Madrid

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine, a wide spectrum of related online degrees and flexible career pathways are available. These programs make it possible to advance your education and professional goals, whether you’re new to the field or seeking specialization.

Healthcare administration is a growing area, and pursuing a cahme accredited Master’s in Health Administration ensures a high standard of curriculum and credibility for leadership roles. Alternatively, those passionate about public health and wellness can consider an online nutrition degree to enter fields like dietetics or health coaching.

Registered nurses looking to advance their careers can benefit from the best online rn to bsn programs without clinical requirements, offering a more streamlined path to obtain a bachelor’s degree. Additionally, experienced nurses can fast-track their education by enrolling in the shortest msn to dnp program to achieve a Doctor of Nursing Practice degree more quickly.

Whether you seek clinical practice or administrative leadership, these online degrees provide flexible options to expand your expertise and broaden your career opportunities in healthcare.

Best Scientists Citing Egbert F. Smit

Trending Scientists

Recently Published Articles